Back to Search
Start Over
Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2019 Dec; Vol. 60 (13), pp. 3266-3271. Date of Electronic Publication: 2019 Jun 21. - Publication Year :
- 2019
-
Abstract
- Diffuse large B-cell lymphoma (DLBCL) transformed from follicular lymphoma (FL) (tDLBCL) has been traditionally associated with an aggressive course, but more recent studies have shown longer survivals. The clinical significance of concurrent FL at the time of diagnosis of DLBCL (cDLBCL/FL) is less clear. We compared outcomes of tDLBCL, cDLBCL/FL, and de novo DLBCL (dDLBCL) and then evaluated the impact of double hit (DH) rearrangements (MYC with BCL2 and/or BCL6) in these subgroups' outcomes. The progression free survival (PFS) and overall survival (OS) were not significantly different among the three groups (dDLBCL, tDLBCL, and cDLBCL/FL). The effect of DH on survival was then analyzed in two subgroups: (1) dDLBCL and (2) tDLBCL + cDLBCL/FL. PFS and OS were significantly shorter in lymphomas with DH in each of these two subgroups. We conclude that DH status drives outcomes in all DLBCLs, regardless of their transformation status.
- Subjects :
- Aged
Antineoplastic Agents, Immunological therapeutic use
Antineoplastic Combined Chemotherapy Protocols
Female
Gene Rearrangement
Humans
Lymphoma, Follicular complications
Lymphoma, Follicular drug therapy
Lymphoma, Follicular genetics
Lymphoma, Large B-Cell, Diffuse drug therapy
Lymphoma, Large B-Cell, Diffuse etiology
Lymphoma, Large B-Cell, Diffuse genetics
Male
Middle Aged
Neoplasms, Multiple Primary drug therapy
Neoplasms, Multiple Primary genetics
Neoplasms, Multiple Primary pathology
Neoplasms, Second Primary drug therapy
Neoplasms, Second Primary genetics
Neoplasms, Second Primary pathology
Progression-Free Survival
Proto-Oncogene Proteins c-bcl-2 genetics
Proto-Oncogene Proteins c-bcl-6 genetics
Proto-Oncogene Proteins c-myc genetics
Retrospective Studies
Rituximab therapeutic use
Time Factors
Cell Transformation, Neoplastic genetics
Lymphoma, Follicular mortality
Lymphoma, Large B-Cell, Diffuse mortality
Neoplasms, Multiple Primary mortality
Neoplasms, Second Primary mortality
Subjects
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 60
- Issue :
- 13
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Academic Journal
- Accession number :
- 31225766
- Full Text :
- https://doi.org/10.1080/10428194.2019.1622099